EU-LIFE Community members held their annual meeting in Barcelona on 23th and 24th of October. This annual event brings the opportunity to strengthen the on-going EU-LIFE collaborations looking for an optimal environment for excellent research. Open science, scientific collaborations, research infrastructure, technology transfer, funding, career development in research were at the heart of the EU-LIFE working groups discussions.
EU-LIFE supports OA to scholarly publications recognizing the rights to every scientist and citizen to access scientific literature (publishing as well as reading and re-using) as we believe science to be a public good for society.
OA implementation requires innovation and a well-thought plan engaging all different actors worldwide. Importantly, OA implementation must ensure high-level quality and fairness of the scientific publication system.
EU-LIFE puts forward 10 key recommendations on the implementation of Plan S.
On July 25th, the Court of Justice of the European Union (ECJ) ruled that organisms obtained by modern forms of mutagenesis such as CRISPR are not exempt from the EU GMO legislation. Consequently, genome edited organisms must comply with the strict conditions of the EU GMO legislation. This is in stark contrast with the opinion of the Advocate-General of the Court, which was published in January of this year and advised ruling otherwise.